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The origin of complex hierarchical superstructures of biomaterials and their unique self-assembly
mechanisms of formation are important in biological systems and have attracted considerable attention.
In the present study, we investigated the morphological changes of calcium oxalate (CaOx) crystals
induced by additives including chiral aspartic acid, sodium citrate, Mg2+, casein and combinations of these
molecules. The morphology and structure of CaOx were identified with the use of various techniques. The
morphogenesis of CaOx crystals were significantly affected by chiral aspartic acid, sodium citrate or Mg
2+.
However, they only formed calcium oxalate monohydrate (COM). It was observed that the chiral aspartic
acid, sodium citrate and casein adhered to the surface of the crystals. The adherence of Mg2+ to crystals
was not evident. Casein significantly affected the formation of COM and calcium oxalate dihydrate (COD).
The ratio of different CaOx crystal forms is associated with the casein concentration. In combination with
Mg2+ or citrate ions, casein showed improved formation of COD. The present study mimics
biomineralization with a simple chemical approach and provides insight into the complicated system of
CaOx biomineralization as well as facilitates the understanding of urinary stone treatment.Introduction
The increasing incidences and prevalence of stone disease is
taking a toll on the social health system worldwide.1–4 The
cause, the process of stone formation, and the different inhib-
itive mechanisms remain elusive.5–7
CaOx is the most frequently encountered crystalline phase in
urethral calculi and renal calculi.3,8–10 CaOx is present in four
crystalline types, namely, anhydrous (COA),11 COM, COD and
trihydrate (COT)12 and an amorphous type (ACO).13,14 The major
component of human urinary stones is COM, COD, or a mixture
of the two species.15,16 Thermodynamically stable COM crystals
with higher adsorptive capability and larger (101) surface area
than those of COD crystals can easily come in contact with renal
tubular cells.17
Understanding morphogenesis of COM facilitates the
explanation of the mechanism of calculus formation and
provides effective strategies for lithiasis diagnosis andand Life Sciences, Wuhan University of
: h.xie@whut.edu.cn
ey Laboratory of Advanced Technology for
niversity of Technology, Wuhan, 430070,
ry, University of Namur, B-5000 Namur,
tion (ESI) available. See DOI:treatment. The controlled crystallization of CaOx has been
investigated in a variety of organic systems including Langmuir
monolayers,18 vesicles,19 micelles,20 citrate,21–23 amino acids24
and natural macromolecules.15,18,25–28 Some urinary proteins2
and polypeptides29 were observed to inhibit stone formation.
These discoveries are signicant for setting up effective thera-
pies for stone disease, which have affected human beings for
thousands of years6,30 and shed light on the complex structure
formation of inorganic materials in an easier way. Due to the
complicated functions and changeable activities of biological
materials during the formation of inorganic materials, more
research needs to be carried out on the shape and structure
control of CaOx crystals.
L-Aspartic acid is abundant in the human body and is
frequently presents in the form of calculus. Some researchers
believe that L-aspartic acid plays a signicant role in preventing
CaOx stone formation.5,31,32 For example, Golovanova et al.
observed that aspartic acid and glutamic acid inhibited the
growth of CaOx crystals.31 However, other researchers did not
agree that L-aspartic acid has a signicant role in affecting the
CaOx stone growth. Guo et al. found that aspartate and gluta-
mate drastically reduced the aspect ratio during pit lling, but
only weakly inhibited the crystal growth.15 The inuence of L-
aspartic acid on CaOx formation is ambiguous. Chirality is an
important issue in crystallization. Many researchers have re-
ported that different chiral materials have signicant difference

































































































View Article Onlineof both L- and D-aspartic acid in CaOx crystallization were
investigated in the present study.
Sodium citrate (Na3 Citrate) is a therapeutic agent of urinary
stone disease. It has been used in clinical treatments for many
years.34,35Mg2+ is abundantly available in nature as well as in the
human body. It can decrease oxalate absorption in the gut,36
which in turn decreases the formation rate of CaOx. Since ions
doped calcium oxalate crystals can be obtained by co-precipi-
tation,37 Mg2+ may also inuence the property of crystallization
of CaOx in this manner. In the present study, the effects of these
two chemicals on CaOx crystallization were also investigated.
In the human body, macromolecules such as proteins may
also affect the CaOx crystallization. Casein is the major phos-
phate protein in bovine milk. It has brilliant Ca2+ binding
property38 and contains numerous L-aspartic residues.39 Higher
concentration of both calcium ions and casein with stirring has
been explored previously.39 However, lower concentration and
non-stirring condition is benecial to obtain the relationship
between additives and the crystal forming process.33 Therefore,
casein was employed as a macromolecular additive to study its
inuence on CaOx crystallization.
The aim of this study was to investigate the crystallization of
CaOx under the inuence of L-aspartic acid, D-aspartic acid,
Mg2+, Na3 Citrate, and casein. Considering the complex envi-
ronment in vivo, where different compositions co-exist, the
effects of combinations of macromolecules and micro mole-
cules on the CaOx crystallization were studied. The morphology
of CaOx as well as polycrystalline superstructures had been
identied by multiple techniques. The formation and
complexity of hierarchical structures of CaOx were evaluated. A
possible self-assembly process of CaOx was discussed. The
present study suggests that it is possible to control the
morphogenesis of CaOx crystalline superstructures by a simple
chemical method mimicking biomineralization.Experimental
Materials
L-Aspartic acid (Bioxtra, $ 99%, HPLC), D-aspartic acid (99%),
and Casein sodium salt from bovine milk were purchased from
Sigma Aldrich. All other chemicals were of analytical grade,
obtained commercially, and used without further purication.
Ultra-pure water (18.2 MU) was used for the preparation of
aqueous solutions in all experiments.Synthetic procedures
Fresh 2.5 mmol L1 Tris–HCl buffer was used to prepare
2 mmol L1 CaCl2 and 2 mmol L
1 Na2C2O4. All solutions were
adjusted to pH 6 at 37 C by HCl or NaOH unless otherwise
stated. CaOx crystals were prepared by mixing equal volume of
CaCl2 and Na2C2O4 solutions and incubating overnight at 37 C.
Appropriate amounts of additives were added into the CaCl2
solution before adjusting the pH if required. Then, the crystal
products were collected by centrifugation (10000 g, 10 minutes)
or ltration through a 0.22 mmnylonmembrane and rinsed three
times with Ultra-pure water. The crystals were then dried at 37 C.This journal is © The Royal Society of Chemistry 2018Characterization techniques
Scanning electron microscopy (SEM). Scanning electron
microscopy (SEM) imaging was performed using a Hitachi S
4800 operating at acceleration voltages of 5 kV. All samples were
coated with gold before test.
Powder X-ray diffraction (XRD). Powder X-ray diffraction
(XRD) patterns of CaOx were acquired using a Bruker AXS D8
Advance diffractometer with Cu Ka (l ¼ 1.5418 Å) operating at
40 kV/40 mA. Data were collected from 5 to 80 with a scanning
rate of 0.05 degree per 0.5 second.
Thermogravimetric analyses (TGA). Thermogravimetric
analyses (TGA) were carried out on a Setaram LABSYS Evo STA
1600. Samples were placed in Al2O3 crucibles without lid and
were heated from room temperature to 1000 C at a heating rate
of 5 C min1 under 20 mL min1 of air atmosphere.
Fourier transform infrared (FTIR). Fourier transform
infrared (FTIR) spectra were recorded on a BRUKER VERTEX
80 V. Samples were ground with potassium bromide (KBr) and
then made into a pellet. Data were collected in the range of 400
to 4000 cm1, in which 64 scans were averaged at a resolution of
4 cm1. Then, in the range of 1580 to 1720 cm1, 1024 scans
were averaged at a resolution of 4 cm1, to show the difference
at the Amide I area between samples and standards.Results and discussion
Inuence of small molecular additives on mineralization of
COM
In the present study, the concentration of Ca2+ and C2O4
2 in
crystallization assays was adjusted to 1 mmol L1 to avoid fast
precipitation of CaOx and acquire sufficient amount of crystals
for analysis. In a preliminary study, to optimise the concentra-
tion of additives, a broad range of concentrations were explored
from 0.1 mmol L1 to 2 mmol L1 (Fig. S1–S4, see ESI†). The
results indicated that for additives Mg2+, D-aspartic acid, and L-
aspartic acid, better crystal morphology can be viewed at
2 mmol L1 of additive concentration. However, it was difficult
to obtain crystals for Na3 Citrate at 2 mmol L
1 even on using
centrifugation (10 000 g, 10 minutes) to collect crystals. Since
the concentration of Na3 Citrate in healthy urine sample is
around 1.1–1.6 mmol L,40–42 the additive concentration of Na3
Citrate was adjusted to 1 mmol L1 for the rest of the study.
Although effects of concentrated additives on crystallization
may be more evident, it is rare in vivo. The addition of small
molecular additives did not change the crystal form of COM
(Fig. 1). Under these conditions, only COM was acquired in the
presence or absence of additives. However, the addition of Mg2+
or Na3 Citrate drastically inuenced the orientation of the
crystals.
The orientation changes of crystals were also observed along
with the pH changes from 4 to 7 (Fig. S5†). Upon the addition of
Mg2+ or Na3 Citrate, larger (101) face of COM was observed as
compared to those of other additives. In addition, relatively
smaller (020) face and (121) face were observed in the presence
of Na3 Citrate, resulting in the hexagon thin plate morphology
of COM. The addition of chiral aspartic acid increased the sizeRSC Adv., 2018, 8, 11014–11020 | 11015
Fig. 1 XRD results of COM acquired with or without the presence of
small molecular additives at pH 6. The additive concentration in
solution was 2 mmol L1 for chiral aspartic acid or Mg2+, and 1 mmol

































































































View Article Onlineof COM and smoothed the edge. To prove the effects of aspartic
acid on crystals, higher concentration of D-aspartic acid and
L-aspartic acid at 20 mmol L1 were tested at both pH 6 and pH
7 (Fig. 2). It was found that the size of the as-formed crystals
were almost double in comparison with that formed in the
absence of additives. However, the amounts of additives
attached to the crystals were insufficient to be detected by TGA
(Fig. S6, Table S1†). In addition, there is evidence of interaction
between CaOx and these additives, particularly for Na3 Citrate,
which is a strong bonding additive to CaOx crystals (Fig. 1).
In most cases, the pH of human urine is around 6. Therefore,
the pH was set to 6 in the present study to investigate the effect
of additives as a function of crystallization time. CaOx crystal
formation is a rapid process. It only takes several minutes for
the precipitation of CaOx minerals aer mixing calcium chlo-
ride solution with sodium oxalate solution at 37 C. The resul-
tant crystals were imperfect with a rough surface, rough edges
and small fragments (Fig. S7†). However, there were differencesFig. 2 SEM images of COM formed in the presence of 20 mmol L1 of
D-aspartic acid (A1, A2) or L-aspartic acid (B1, B2). The pH solution was
pH6 (A1, B1) and pH7 (A2, B2).
11016 | RSC Adv., 2018, 8, 11014–11020between the effects of different additives. Chiral aspartic acid
did not have signicant inuence on the crystals at this
concentration. Both Mg2+ and Na3 Citrate can make the (101)
face larger even in a short crystallization time. Additives might
affect the crystal morphogenesis in two ways. One is that
additives attached to the crystal face increased the stability by
inactivating the dissolution and recrystallization process on
this face. The other is that additives reduced the dissolution
process by increasing the compete stress in solution.
Since there may be dissolution and recrystallization cycles,
roles of additives were further studied in the ageing process of
crystallization (Fig. 3). In a relatively long crystalline process
without any additives, CaOx crystals formed irregular shapes in 3
days. This is owing to the constant dissolution and recrystalliza-
tion process with limited ion resources. In the presence of small
molecular additives, most crystals retain their relatively complete
(101) face. Aer 3 days, there were holes on the (020) face of
crystals formed in chiral aspartic acid added solution. Some even
changed to a sponge-like morphology in 10 days (Fig. S8†).
In combining this result with TGA (Fig. S6 and Table S1†)
and energy dispersive spectrometry (EDS) (Fig. S9†), it is
supposed that the binding of chiral aspartic acid to crystals is
specic, which is coincident with the results reported by Grohe
et al.43 and He et al.24 Na3 Citrate could function in the same
manner, while Mg2+ functions in another. EDS analysis showed
that Mg2+ was not present in COM, although addition of Mg2+
did change the crystal shape. If MgC2O4$H2O or MgC2O4$2H2O
were present, the TGA spectrum would conrm that the total
weight loss was higher than that of pure COM. However, this
did not occur as shown in Table S1.† Therefore, we concluded
that there was no detectable Mg2+ in the formed crystals on
addition of 2 mmol L1 Mg2+. This situation is quite different
from Fe2+ doping in calcium oxalate.37Inuence of casein on introducing dihydrate form of CaOx
Macromolecules such as proteins can function as templates or
catalysts in the biomineralization processes. Liu et al. reported
the production of dumbbell-shaped CaOx in the presence of
amphiphilic phosphoproteins.25,39 They investigated effects of
casein on the morphogenesis of CaOx at pH 6.9 at room
temperature. However, this condition is different to that in vivo.
In order to obtain insight of natural biomineralization, we
explored the inuence of casein on mineralization of CaOx at
pH 6 at 37 C, which mimics the in vivo condition. Completely
different morphology and crystal types were obtained in
comparing with the previous study.25,39
Casein (ranging from 0.1 g L1 to 4.0 g L1) induced changes
in the crystal morphology as well as crystal form (Fig. 4 and 5).
Most of the crystals are fragments with a rough surface and
branch inside (Fig. 4, A1 to F1). The crystal surface changed along
with the addition of different amounts of casein (Fig. 4, A2 to F2),
but not in a streak manner. The core region of the cross section
was a bunch of branch-like crystals, elongating near the surface,
which converted into particles (Fig. 4, A3 to F3).
XRD spectra (Fig. 5) showed that the intensity of the peaks
belonging to COM decreased upon increasing caseinThis journal is © The Royal Society of Chemistry 2018
Fig. 3 SEM images show the change of CaOx crystallization time form
0.5 day to 3 days. (A) CaOx, (B) CaOxwith D-aspartic acid, (C) CaOxwith
L-aspartic acid, (D) CaOx with Mg
2+, (E) CaOx with Na3 Citrate. 1 to 2
refers to 0.5 day and 3 days, separately.
Fig. 4 CaOx formed within different concentration of casein in solu-
tion. (A) 0.1 g L1, (B) 0.2 g L1, (C) 0.4 g L1, (D) 0.8 g L1, (E) 2 g L1, (F)
4 g L1. 1 is the overview, 2 is magnification of 1 to show the crystal
surface, 3 is magnification of 1 also to show the cross section.
Fig. 5 XRD results illustrate changing from COM to COD formed with

































































































View Article Onlineconcentration, while intensity of COD peaks increased. This
implied that more COD was formed along with involvement of
more casein. Upon casein treatment, XRD peaks of CaOx
minerals were lower with wider full width at half maximum
(FWHM) and uneven baselines. This implied the change of
crystallinity or crystallographic texture. The change in XRD
pattern might be due to the deposition of casein on the crystals
and changes in the crystals structure. The impure crystals were
fragile and readily broke during the treatment process, result-
ing in most crystals broken into small fragments.
Theoretically, the total weight loss of pure COM is 61.62%,
while this value is 65.83% for that of pure COD. Addition of
casein induced formation of COD (as proven by XRD), which

































































































View Article Onlinecasein in solution (Table S2†), total weight loss was higher than
65.83%, indicating that COD is not the only composition in the
sample (can be proven by XRD). This implies that casein may
contribute to the increase in weight loss.Inuence of combinations of additives on CaOx
mineralization
A living organism is a quite complex system, in which various
molecules work together to maintain the essential biochemical
and physiological processes. In a biomineralization process, the
formation of biomineral requires functions from both macro-
molecules (mineral proteins) and small molecules (ions). In the
present study, the effects of casein on CaOx mineralization was
further explored in the presence of Mg2+ or Na3 Citrate (Fig. 6).
Small crystals were obtained with rough surface and different
shapes.Fig. 6 COD formed with casein and small molecular additives. (A)
0.1 g L1 casein + 2 mmol L1 Mg2+, (B) 0.2 g L1 casein + 2 mmol L1
Mg2+, (C) 0.1 g L1 casein + 1 mmol L1 Na3 Citrate, (D) 0.2 g L
1 casein
+ 1 mmol L1 Na3 Citrate. (E) XRD spectra of COD formed with
additives.
11018 | RSC Adv., 2018, 8, 11014–11020The involvement of casein in CaOx mineralization in the
presence of Mg2+ or Na3 Citrate was analysed by TGA. The
amount of casein contained in the crystals increased on
addition of Mg2+ (Table 1, Fig. S10†). In this study, COM was
acquired in the presence of Mg2+ (Fig. 1) and it did not
signicantly affect the TGA results (Fig. S6, Table S1†). When
casein was included in the crystallization assay, it resulted in
weight loss, which was much more signicant if Mg2+ was also
included (Table 1). The weight loss may be either due to the
increase in amount of COD or due to the increase in amount
of casein in the crystals. This is supported by the fact that
weight loss of crystals formed in the presence of 0.2 g L1
casein and Mg2+ is higher than that of pure COD and close to
that formed in the presence of 0.8 g L1 casein (Table S2†).
However, the weight loss of the crystals formed in the pres-
ence of 0.1 g L1 casein and Mg2+ is close to that of pure COD
since COM may be included. We previously reported that
addition of Mg2+ can increase the size of casein micelles.44
The unique structure of casein micelles facilitates absorption
of Ca2+ and subsequent interaction with the oxalate ions.
Then, casein micelles form single small particles, which can
function as the core of crystallization and assembly template.
It allows fusion of small COD particles into branch-like
structures of the resultant morphology. Since citrate can co-
deposit with crystals (Table S1†), weight change (Table 1) of
crystals can be due to COD (Fig. 6) and co-deposited citrate
(Table S1†). Citrate can attract more Ca2+ and increase the
ratio of Ca2+/C2O4
2 around crystal, which functions with
casein to induce COD formation. Signicant depletion of
water was observed at low temperature in the TGA for crystals
in the presence of Mg2+ or Na3 Citrate. This may be due to the
water in COD, which is weakly bonded in crystals than in
COM45 or can be attributed to the interactions between
deposited casein and water molecules.
The deposition of casein on CaOx crystals were also analysed
by XPS spectrometry (Fig. 7 & Table 2). XPS results show the
percentage of atoms in the crystal surface. It conrmed the
presence of casein by increasing the amount of N atoms, which
were present only in casein in this situation. The increasing
amount of C was attributed to casein or Na3 Citrate. The peak of
magnesium is not evident. This implies that the role of Mg2+ in
solution is to upregulate the stress of bivalent cations and then








CaOx 14.5 18.4 27.3 60.2
Casein from Sigma 14.7 60.8 17.3 92.8
Casein 4 g L1 18.2 36.9 17.6 72.7
Casein 0.2 g L1 + Mg2+ 25.8 24.1 19.5 69.4
Casein 0.2 g L1 + Na3 Citrate 22.5 24.4 18.7 65.6
Casein 0.2 g L1 16.7 27.5 20.3 64.5
Casein 0.1 g L1 + Mg2+ 22.2 24.5 18.6 65.3
Casein 0.1 g L1 + Na3 Citrate 21.6 23.6 18.0 63.2
Casein 0.1 g L1 15.6 26.7 20.7 63.0
This journal is © The Royal Society of Chemistry 2018
Fig. 7 XPS survey scan for CaOx crystals formed within different
additives in solution (A) CaOx, (B) 0.2 g L
1 casein, (C) 0.2 g L1 casein +
2 mmol L1 Mg2+, (D) 0.2 g L1 casein + 1 mmol L1 Na3 Citrate.
Table 2 Surface atomic percentage of casein included samples
Sample C 1s Ca 2p N 1s O 1s Mg 1s
CaOx 15.11 15.58 1.25 67.85 0.22
Casein 62.18 1.55 13.78 22.34 0.15
Casein–Mg2+ 61.81 3.33 10.21 24.52 0.13
Casein–Na3 Citrate 71.20 2.67 7.15 18.88 0.11
Fig. 8 FTIR results illustrate the influence of additives on CaOx.

































































































View Article OnlineThe interaction between casein and minerals was analysed
by FTIR (Fig. 8). The symmetrical stretching vibration and
asymmetrical stretching vibration of C]O bonds from oxalate
were assigned to 1317 cm1 and 1616 cm1. The absorptionThis journal is © The Royal Society of Chemistry 2018bands in amide I region between 1600–1700 cm1 corresponds
to the secondary structure of the polypeptide backbone.38 This
area was explored to obtain structural information of casein
during the crystallization (Fig. 9). In the absence of casein, the
acquired crystals only exhibit a characteristic peak of CaOx
around 1616 cm1. Upon addition of casein without other
additives, there was a red shi of the absorbance peak to
1616 cm1. However, no characteristic peaks of proteins were
observed in the spectrum. Upon addition of casein together
with Mg2+ or Na3 Citrate, there were characteristic peaks at
1645 cm1 and 1664 (1669) cm1, which are related to the
uncoiling and turning of the protein structure. Therefore, Mg2+
or Na3 Citrate might promote the interactions between casein
and crystals.Conclusions
In the present study, we explored the morphological and
structural changes of CaOx crystals induced by additives
including chiral aspartic acid, sodium citrate, Mg2+, casein and
a variety of combination of these molecules. The difference was
not signicant between L-aspartic acid and D-aspartic acid on
affecting the COM formation. The adhesion of aspartic acid on
CaOx (101) face was proved by monitoring the ageing process of
CaOx mineralization. Casein could affect the morphogenesis
of CaOx minerals. However, its function was limited at low
concentrations. Adherence of Na3 Citrate to the crystals was
observed. It facilitated the Ca2+ ions to adhere around the
crystals, which affected the morphogenesis and improved the
COD formation in the presence of casein. Mg2+ regulated
interactions between casein and CaOx minerals through
increasing casein micelle size, which subsequently improved
the function of casein at low concentration. This observation is
helpful for understanding molecular interactions and behav-
iours in vivo, for systems which are full of ions, proteins and
other small or macro molecules. These molecules may function
together in various physiological and biochemical processes as
that of casein and other small molecules in biomineralization of
CaOx. The present study helps us explore principles and
mechanisms for the formation of crystalline superstructures as
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